Intelligent matrices for tumor-specific cytotoxic T lymphocytes

被引：0
|
作者：
Liu, Shu Qin [1 ]
Saijo, Kaoru [1 ]
Kodama, Makoto [1 ]
Ohno, Tadao [1 ]
机构：
[1] RIKEN, Tsukuba, Japan
来源：
Materials Science and Engineering C | 1994年 / 2卷 / 1-2期
关键词：
18;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 65
相关论文
共 50 条
  • [31] Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function
    Gati, A
    Guerra, N
    Giron-Michel, J
    Azzarone, B
    Angevin, E
    Moretta, A
    Chouaib, S
    Caignard, A
    CANCER RESEARCH, 2001, 61 (08) : 3240 - 3244
  • [32] Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts
    Mackensen, A
    Veelken, H
    Lahn, M
    Wittnebel, S
    Becker, D
    Kohler, G
    Kulmburg, P
    Brennscheidt, U
    Rosenthal, F
    Franke, B
    Mertelsmann, R
    Lindemann, A
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (04): : 290 - 296
  • [33] Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts
    Andreas Mackensen
    Hendrik Veelken
    Michael Lahn
    Sebastian Wittnebel
    Daniel Becker
    Gabriele Köhler
    Peter Kulmburg
    Ulrich Brennscheidt
    Felicia Rosenthal
    Brigitte Franke
    Roland Mertelsmann
    A. Lindemann
    Journal of Molecular Medicine, 1997, 75 : 290 - 296
  • [34] Cytotoxic T-cells with grafted, tumor-specific recognition functions
    Groner, B
    Klundt, E
    Altenschmidt, U
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 32 - 32
  • [35] EFFECT OF BETA-CAROTENE ON CYTOTOXIC ACTIVITY AND RECEPTOR EXPRESSION OF TUMOR-SPECIFIC LYMPHOCYTES
    AKPORIAYE, ET
    PETERSEN, A
    PIERCE, P
    VALENZUELA, J
    CANFIELD, L
    BENDER, J
    CAROTENOIDS IN HUMAN HEALTH, 1993, 691 : 264 - 266
  • [36] GENERATION OF TUMOR-SPECIFIC T-LYMPHOCYTES FOR THE TREATMENT OF POSTTRANSPLANT LYMPHOMA
    DIMAIO, JM
    VANTRIGT, P
    GAYNOR, JW
    DAVIS, RD
    COVENEY, E
    CLARY, BM
    LYERLY, HK
    CIRCULATION, 1995, 92 (09) : 202 - 205
  • [37] CONCOMITANT PRESENCE OF TUMOR-SPECIFIC CYTOTOXIC AND INHIBITOR LYMPHOCYTES IN PATIENTS WITH OSTEOGENIC-SARCOMA
    YU, A
    WATTS, H
    JAFFE, N
    PARKMAN, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (03): : 121 - 127
  • [38] Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
    Baxevanis, CN
    Voutsas, IF
    Tsitsilonis, OE
    Gritzapis, AD
    Sotiriadou, R
    Papamichail, M
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3902 - 3912
  • [39] Histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of a patient with testicular embryonal cancer
    Suekane, S
    Nakao, M
    Inoue, M
    Noda, S
    Itoh, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1181 - 1189
  • [40] Administrations of Tumor-Specific Cytotoxic T Lymphocytes Engineered to Resist TGF-β to Patients with EBV-Associated Lymphomas
    Bollard, Catherine M.
    Dotti, Gianpietro
    Gottschalk, Stephen
    Liu, Enli
    Sheehan, Andrea
    Mims, Martha
    Liu, Hao
    Gee, Adrian P.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Rooney, Cliona M.
    BLOOD, 2010, 116 (21) : 248 - 248
12345